The Globe and Mail reports in its Thursday, Nov. 7, edition that RBC Capital analyst Darko Mihelic has reaffirmed his "outperform" recommendation for Sun Life Financial. The Globe's David Leeder writes in the Eye On Equities column that Mr. Mihelic jacked his share target up by $5 to $82. Analysts on average target the shares at $83.15. Mr. Mihelic says in a note: "Sun Life Financial had a stronger than expected quarter with strength in the U.S. segment and better than anticipated U.S. dental results that had bounced back to a profit in Q3/24. We see a good setup for 2025 as Sun Life reprices dental premiums and the lifeco has solid capital which it is returning to shareholders via buybacks. We also believe the lifeco can improve on Asia results and look forward to its investor day next week." The Globe reported on Feb. 9 and Aug. 15 that Mr. Mihelic continued to rate Sun Life "outperform." The shares could then be had for $71.47 and $69.90. The Globe reported on Oct. 31 that Scotia Capital analyst Meny Grauman continued to rate Sun Life "sector outperform." The shares were then going for $78.61.